D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$708M |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$614M |
| 3 |
Merck
MRK
|
+$521M |
| 4 |
Bank of America
BAC
|
+$492M |
| 5 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$646M |
| 2 |
Tesla
TSLA
|
+$607M |
| 3 |
Microsoft
MSFT
|
+$491M |
| 4 |
Accenture
ACN
|
+$482M |
| 5 |
Broadcom
AVGO
|
+$438M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.84% |
| 2 | Consumer Discretionary | 9.28% |
| 3 | Healthcare | 6.84% |
| 4 | Financials | 6.63% |
| 5 | Industrials | 5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
CALL
Snap
SNAP
$7.6B
| $9.1M | 0.01% |
850,300
-2,950,800
| -78% | -$33.7M |
|
|
UCTT
1377
Ultra Clean Holdings
UCTT
$3.9B
| $9.09M | 0.01% |
+227,685
| New | +$9.34M |
|
|
SAND
1378
DELISTED
Sandstorm Gold
SAND
| $9.07M | 0.01% |
1,511,560
+1,310,453
| +652% | +$7.45M |
|
|
CSGS
1379
DELISTED
CSG Systems International
CSGS
| $9.03M | 0.01% |
185,688
-82,353
| -31% | -$3.75M |
|
1380
US Foods
USFD
$21.9B
| $9.02M | 0.01% |
146,608
+66,893
| +84% | +$3.74M |
|
1381
Chegg
CHGG
$110M
| $8.99M | 0.01% |
5,079,781
+135,863
| +3% | +$333K |
|
1382
Viatris
VTRS
$20.5B
| $8.96M | 0.01% |
771,991
-152,702
| -17% | -$1.76M |
|
1383
Paychex
PAYX
$41.1B
| $8.93M | 0.01% |
66,562
-28,296
| -30% | -$3.59M |
|
|
SMAR
1384
DELISTED
Smartsheet Inc.
SMAR
| $8.93M | 0.01% |
161,222
-249,860
| -61% | -$12.1M |
|
1385
Kymera Therapeutics
KYMR
$9.05B
| $8.91M | 0.01% |
188,197
-107,375
| -36% | -$4.74M |
|
1386
Murphy USA
MUSA
$11.3B
| $8.9M | 0.01% |
18,056
-1,553
| -8% | -$779K |
|
1387
Axogen
AXGN
$2.19B
| $8.89M | 0.01% |
634,344
+25,759
| +4% | +$285K |
|
1388
CALL
FMC
FMC
$1.39B
| $8.89M | 0.01% |
134,800
-25,000
| -16% | -$1.53M |
|
1389
PUT
Rio Tinto
RIO
$150B
| $8.87M | 0.01% |
124,600
+51,400
| +70% | +$3.3M |
|
|
LGF.B
1390
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $8.84M | 0.01% |
1,276,845
+260,755
| +26% | +$1.96M |
|
1391
TKO Group
TKO
$13.7B
| $8.83M | 0.01% |
+71,405
| New | +$8.17M |
|
1392
CALL
KLA
KLAC
$266B
| $8.83M | 0.01% |
+114,000
| New | +$8.94M |
|
1393
PUT
Phillips 66
PSX
$83.3B
| $8.82M | 0.01% |
67,100
+47,800
| +248% | +$6.45M |
|
1394
Summit Therapeutics
SMMT
$10.5B
| $8.81M | 0.01% |
402,167
+372,467
| +1,254% | +$5.21M |
|
1395
RE/MAX Holdings
RMAX
$207M
| $8.77M | 0.01% |
704,521
+1,093
| +0.2% | +$11.3K |
|
1396
Prudential
PUK
$36.6B
| $8.76M | 0.01% |
472,373
-189,469
| -29% | -$3.31M |
|
1397
Jacobs Solutions
J
$16B
| $8.73M | 0.01% |
67,393
+43,443
| +181% | +$5.24M |
|
1398
Weatherford International
WFRD
$6.16B
| $8.73M | 0.01% |
102,758
+49,527
| +93% | +$5.34M |
|
1399
Heron Therapeutics
HRTX
$86.9M
| $8.73M | 0.01% |
4,384,677
+521,302
| +13% | +$1.24M |
|
1400
MediaAlpha
MAX
$734M
| $8.7M | 0.01% |
480,571
+35,897
| +8% | +$572K |
|
Similar funds
D.E. Shaw & Co's Q3 2024 Portfolio in Review
As of Q3 2024, D.E. Shaw & Co held 5,052 positions worth $116B, up 8.9% from $107B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
D.E. Shaw & Co's Q3 2024 filing shows 599 new, 1,568 increased, 1,742 reduced and 558 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 1,429,800 shares worth $115M. The largest sale was Adobe, an estimated $646M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q3 2024 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 1,429,800 shares worth $115M.
- D.E. Shaw & Co added most to NVIDIA in Q3 2024, an estimated $708M increase.
- D.E. Shaw & Co's biggest Q3 2024 reduction was Adobe, cutting an estimated $646M.
- D.E. Shaw & Co fully exited WestRock Company in Q3 2024, selling an estimated $148M.
- D.E. Shaw & Co's ten largest holdings make up 9.6% of its $116B portfolio in Q3 2024.
- D.E. Shaw & Co opened 599 new positions and closed 558 in Q3 2024.
- D.E. Shaw & Co's portfolio value rose 8.9% quarter-over-quarter to $116B.
Based on D.E. Shaw & Co's 13F filing for Q3 2024, filed 14 Nov 2024.